Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND1N) Q3 2025 Earnings Report

0 Followers

MX:ASND1N Q3 2025 EPS Results

Actual EPS
-MXN 20.28
Consensus EPS
-MXN 4.95
Beat/Miss
Missed by -MXN 15.33
One Year Ago EPS
-MXN 34.88

MX:ASND1N Q3 2025 Revenue Results

Actual Revenue
MXN 4.61B
Expected Revenue
MXN 4.32B
Beat/Miss
Beat by +MXN 281.20M
YoY Revenue Growth
+292.96%

Earnings Announcement Details

Quarter
Q3 2025
Date
11/12/2025
Time
After Close
Conference Call
Wednesday, November 12, 2025
MX:ASND1N Upcoming Earnings

Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q3 2025 Earnings Call Audio

MX:ASND1N Q3 2025 Earnings Call
0:00 / 0:00

Q3 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:ASND1N Earnings History

MX:ASND1N earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 17, 20272026 (Q4)32.85--11.15――
Nov 12, 20262026 (Q3)16.1221.90-20.28208.00% (+42.18)
Aug 13, 20262026 (Q2)30.3657.39-16.63445.12% (+74.02)
May 07, 20262026 (Q1)―197.72-32.04717.09% (+229.76)
Feb 11, 20262025 (Q4)-1.62-11.15-12.9814.06% (+1.83)
Nov 12, 20252025 (Q3)-4.95-20.28-34.8841.86% (+14.60)
Aug 07, 20252025 (Q2)-26.08-16.63-38.7357.07% (+22.10)
May 01, 20252025 (Q1)-29.75-32.04-46.6431.30% (+14.60)
Feb 12, 20252024 (Q4)-19.95-12.98-31.2358.44% (+18.25)
Nov 14, 20242024 (Q3)-31.74-34.88-54.5536.06% (+19.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed